Psychiatry and Neurology, Neurology · Providence, RI
NPI
1770511446
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
4
Medicare group memberships
Hospitals
3
Hospital affiliations
593 Eddy St, Apc-5
Providence, RI, 02903
Phone (401) 444-3032
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.0M
145,725 services
Medicare patients, 2024
168
Average age 67
Drug cost, 2024
$1.8M
2,897 prescriptions
Company payments, 2024
$5,272
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Syed A Rizvi was code J0174 (injection, lecanemab-irmb, 1 mg), 116,144 times for 16 patients. In total Syed A Rizvi billed 145,725 services in 23 codes, and Medicare paid $1.0M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-12-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0174 Injection, lecanemab-irmb, 1 mg | Office | 116,144 | 16 | $1.05 | $122K |
| J2350 Injection, ocrelizumab, 1 mg | Office | 11,401 | 15 | $44.73 | $510K |
| 96365 Intravenous Infusion, Hydration | Office | 248 | 29 | $50.66 | $13K |
| 99214 Office E&M - Established | Office | 101 | 82 | $81.24 | $8,206 |
| 99215 Office E&M - Established | Office | 55 | 41 | $132.04 | $7,262 |
| 96415 Chemotherapy Administration | Office | 47 | 19 | $21.80 | $1,025 |
| 99231 Hospital E&M - Subsequent | Facility | 35 | 14 | $38.94 | $1,363 |
| 96413 Chemotherapy Administration | Office | 34 | 20 | $96.42 | $3,278 |
| 99205 Office E&M - New | Office | 20 | 20 | $163.93 | $3,279 |
| 96367 Intravenous Infusion, Hydration | Office | 19 | 11 | $21.68 | $412 |
By year: 2022 $888K for 31,297 services; 2023 $657K for 23,932 services; 2024 $1.0M for 145,725 services.
Medicare prescription drug claims, 2024
In 2024, the drug Syed A Rizvi prescribed most often to Medicare patients was Gabapentin, with 332 prescriptions and refills. In total Syed A Rizvi wrote 2,897 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 332 | 448 | 69 | $8,553 |
| Baclofen Generic | 276 | 497 | 71 | $8,688 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 218 | 218 | 29 | $6,302 |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 130 | 130 | 22 | $3,641 |
| Clonazepam Generic | 94 | 106 | 16 | $925 |
| Dextroamphetamine-Amphet Er Dextroamphetamine/Amphetamine | 90 | 90 | 14 | $4,109 |
| Oxycodone Hcl Generic | 79 | 79 | Under 11 | $1,000 |
| Sumatriptan Succinate Generic | 70 | 70 | 17 | $5,185 |
| Dalfampridine Er Dalfampridine | 66 | 86 | 13 | $35K |
| Tizanidine Hcl Generic | 65 | 89 | 12 | $801 |
| Modafinil Generic | 62 | 82 | 15 | $2,525 |
| Duloxetine Hcl Generic | 62 | 108 | 15 | $1,629 |
| Methylphenidate Hcl Generic | 57 | 57 | Under 11 | $1,495 |
| Carbamazepine Generic | 55 | 103 | 16 | $1,996 |
| Diazepam Generic | 52 | 52 | 14 | $204 |
Brand drugs: - claims; generic drugs: 2,647 claims; opioid claims: 388.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Syed A Rizvi $5,272 ($5,272 in general payments such as food, travel and fees) from 3 companies. The largest payer was Amgen Inc. with $3,558.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.